New hope for children with Rapid-Aging disease as experimental drug enters next testing phase
Disease control
Ongoing
This study aims to find the best dose and check the safety of a new drug called progerinin for children with Hutchinson-Gilford progeria syndrome, a rare and severe rapid-aging disease. Ten participants will either take the standard treatment alone or combined with progerinin. Th…
Phase: PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC